AI-Accelerated Drug
Candidate Screening
Patent cliffs demand faster pipeline refill than wet-lab screening allows. Generative AI molecular design models predict compound binding affinity, toxicity, and bioavailability — before a single synthesis occurs — compressing 4–5 years of discovery into 18–24 months.